These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 33476372)
1. The low level of O antigen in Salmonella enterica Paratyphi A is due to inefficiency of the glycosyltransferase WbaV. Liu MA; Kidambi A; Reeves PR FEMS Microbiol Lett; 2021 Feb; 368(3):. PubMed ID: 33476372 [TBL] [Abstract][Full Text] [Related]
2. Multiple immunodominant O-epitopes co-expression in live attenuated Salmonella serovars induce cross-protective immune responses against S. Paratyphi A, S. Typhimurium and S. Enteritidis. Li P; Zhang K; Lei T; Zhou Z; Luo H PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010866. PubMed ID: 36228043 [TBL] [Abstract][Full Text] [Related]
3. The O-antigen negative ∆wbaV mutant of Salmonella enterica serovar Enteritidis shows adaptive resistance to antimicrobial peptides and elicits colitis in streptomycin pretreated mouse model. Jaiswal S; Pati NB; Dubey M; Padhi C; Sahoo PK; Ray S; Arunima A; Mohakud NK; Suar M Gut Pathog; 2015; 7():24. PubMed ID: 26346801 [TBL] [Abstract][Full Text] [Related]
4. Vi Capsular Polysaccharide Produced by Recombinant Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685 [TBL] [Abstract][Full Text] [Related]
5. An essential serotype recognition pocket on phage P22 tailspike protein forces Salmonella enterica serovar Paratyphi A O-antigen fragments to bind as nonsolution conformers. Andres D; Gohlke U; Broeker NK; Schulze S; Rabsch W; Heinemann U; Barbirz S; Seckler R Glycobiology; 2013 Apr; 23(4):486-94. PubMed ID: 23292517 [TBL] [Abstract][Full Text] [Related]
6. Attenuated Liu Q; Li P; Luo H; Curtiss R; Kong Q Virulence; 2019 Dec; 10(1):82-96. PubMed ID: 31874075 [No Abstract] [Full Text] [Related]
7. Selective amplification of tyv (rfbE), prt (rfbS), viaB, and fliC genes by multiplex PCR for identification of Salmonella enterica serovars Typhi and Paratyphi A. Hirose K; Itoh K; Nakajima H; Kurazono T; Yamaguchi M; Moriya K; Ezaki T; Kawamura Y; Tamura K; Watanabe H J Clin Microbiol; 2002 Feb; 40(2):633-6. PubMed ID: 11825983 [TBL] [Abstract][Full Text] [Related]
8. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003. Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897 [TBL] [Abstract][Full Text] [Related]
9. Screening method for Salmonella enterica serovar Typhi and serovar Paratyphi A with reduced susceptibility to fluoroquinolones by PCR-restriction fragment length polymorphism. Hirose K; Tamura K; Watanabe H Microbiol Immunol; 2003; 47(2):161-5. PubMed ID: 12680720 [TBL] [Abstract][Full Text] [Related]
10. One-step differential detection of Salmonella enterica serovar Typhi, serovar Paratyphi A and other Salmonella spp. by using a quadruplex real-time PCR assay. Teh CSJ; Lau MY; Chong CW; Ngoi ST; Chua KH; Lee WS; Thong KL J Microbiol Methods; 2021 Apr; 183():106184. PubMed ID: 33662480 [TBL] [Abstract][Full Text] [Related]
11. Status of paratyphoid fever vaccine research and development. Martin LB; Simon R; MacLennan CA; Tennant SM; Sahastrabuddhe S; Khan MI Vaccine; 2016 Jun; 34(26):2900-2902. PubMed ID: 27083427 [TBL] [Abstract][Full Text] [Related]
12. Structural analysis of the O-acetylated O-polysaccharide isolated from Salmonella paratyphi A and used for vaccine preparation. Ravenscroft N; Cescutti P; Gavini M; Stefanetti G; MacLennan CA; Martin LB; Micoli F Carbohydr Res; 2015 Mar; 404():108-16. PubMed ID: 25665787 [TBL] [Abstract][Full Text] [Related]
13. Purification of O-specific polysaccharide from lipopolysaccharide produced by Salmonella enterica serovar Paratyphi A. Kothari S; Kim JA; Kothari N; Jones C; Choe WS; Carbis R Vaccine; 2014 May; 32(21):2457-62. PubMed ID: 24631090 [TBL] [Abstract][Full Text] [Related]
14. Regulated Delayed Su H; Liu Q; Wang S; Curtiss R; Kong Q Theranostics; 2019; 9(12):3565-3579. PubMed ID: 31281498 [No Abstract] [Full Text] [Related]
15. Complete genome sequence of Salmonella enterica serovar Sendai shows H antigen convergence with S. Miami and recent divergence from S. Paratyphi A. Feng Y; Lin E; Zou S; Chen CL; Chiu CH BMC Genomics; 2019 May; 20(1):398. PubMed ID: 31117944 [TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate. Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100 [TBL] [Abstract][Full Text] [Related]
17. Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD. Zhu C; Xiong K; Chen Z; Hu X; Li J; Wang Y; Rao X; Cong Y Microbiol Immunol; 2015 Aug; 59(8):443-51. PubMed ID: 26084199 [TBL] [Abstract][Full Text] [Related]
18. Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains. Pakkanen SH; Kantele JM; Kantele A Scand J Immunol; 2014 Mar; 79(3):222-9. PubMed ID: 24383914 [TBL] [Abstract][Full Text] [Related]
19. Characterization of pathogenic and resistant genome repertoire reveals two clonal lines in Salmonella enterica subsp. enterica serovar Paratyphi B (+)-tartrate positive. Huehn S; Helmuth R; Bunge C; Guerra B; Junker E; Davies RH; Wattiau P; van Pelt W; Malorny B Foodborne Pathog Dis; 2009 May; 6(4):431-43. PubMed ID: 19292689 [TBL] [Abstract][Full Text] [Related]
20. Heterologous Pseudomonas aeruginosa O-antigen delivery using a Salmonella enterica serovar Typhimurium wecA mutant strain. Bridge DR; Whitmire JM; Makobongo MO; Merrell DS Int J Med Microbiol; 2016 Nov; 306(7):529-540. PubMed ID: 27476047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]